Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Gene Therapy Start-Up Raises $41M in Early Funds

A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round. . . . → Read More: Gene Therapy Start-Up Raises $41M in Early Funds

NSF Supports Chip Enabling Low-Power Electronics

An engineering lab at University of Texas in San Antonio received a grant to assess the commercial potential for a chip that lets electronic devices work with much less power. . . . → Read More: NSF Supports Chip Enabling Low-Power Electronics

$175K Challenge Seeks New Antimicrobial Preservatives

A new challenge competition on InnoCentive is seeking development of new types of preservatives for personal care and other household products. . . . → Read More: $175K Challenge Seeks New Antimicrobial Preservatives

Vaccine R&D Underway to Protect Against Animal Microbes

Research is underway in the U.K. on development of new vaccines to protect humans against zoonotic diseases, infectious diseases originating in animals. . . . → Read More: Vaccine R&D Underway to Protect Against Animal Microbes

Neural Technology Research Centers Launched

Research centers for accelerating new technologies that tackle nervous system disorders are opening at two universities in the U.S., with industry partners. . . . → Read More: Neural Technology Research Centers Launched

Research, Medical Groups Join Science March

A collection of 25 organizations representing a range of medical research and practice disciplines announced their participation in the March for Science set for Saturday, 22 April. . . . → Read More: Research, Medical Groups Join Science March

Cancer Gene Therapy Company Raises $85M in IPO

A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering. . . . → Read More: Cancer Gene Therapy Company Raises $85M in IPO

NIH Funds Drug-Resistant Malaria Therapy Trial

An agency of National Institutes of Health is funding a clinical trial of a new malaria drug engineered to overcome resistance developed to earlier treatments. . . . → Read More: NIH Funds Drug-Resistant Malaria Therapy Trial

Student Project Leads to Medical Device Start-Up

A group of engineering and business students developing an imaging device that quickly finds veins for blood draws is starting a company to take the device to market. . . . → Read More: Student Project Leads to Medical Device Start-Up

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D